RFP | March 24, 2014
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases announces the availability of funding for implementation of the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus: Network Leadership Center (UM2) Program Project or Center With Complex Structure Grant. The goal of the program is to ascertain and define shared and disease-specific biological pathways in order to identify relevant drug targets for the treatment of rheumatoid arthritis, lupus, and related autoimmune diseases. Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute . . .